Related Experiment Video

Updated: Jan 3, 2026

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.7K

Risk of malignancy in patients treated for systemic necrotising vasculitis

Antoine Lafarge1,2, Adrien Joseph3, Christian Pagnoux4

  • 1Department of Internal Medicine, Cochin Hospital, Paris, France antoinelafarge@outlook.com benjamin.terrier@aphp.fr.

Annals of the Rheumatic Diseases
|November 27, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cancercyclophoshamideimmunosuppressive agentsrituximabvasculitis

More Related Videos

Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research09:36

Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research

Published on: April 26, 2019

6.1K

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
341